Author
Listed:
- Noam D. Beckmann
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Wei-Jye Lin
(Sun Yat-Sen University
Sun Yat-sen University
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Minghui Wang
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Ariella T. Cohain
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Alexander W. Charney
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Pei Wang
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Weiping Ma
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Ying-Chih Wang
(Icahn School of Medicine at Mount Sinai)
- Cheng Jiang
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Mickael Audrain
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Phillip H. Comella
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Amanda K. Fakira
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Siddharth P. Hariharan
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Gillian M. Belbin
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Kiran Girdhar
(Icahn School of Medicine at Mount Sinai)
- Allan I. Levey
(Emory University School of Medicine)
- Nicholas T. Seyfried
(Emory University School of Medicine
Emory University School of Medicine)
- Eric B. Dammer
(Emory University School of Medicine)
- Duc Duong
(Emory University School of Medicine
Emory University School of Medicine)
- James J. Lah
(Emory University School of Medicine)
- Jean-Vianney Haure-Mirande
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Ben Shackleton
(Icahn School of Medicine at Mount Sinai)
- Tomas Fanutza
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Robert Blitzer
(Icahn School of Medicine at Mount Sinai)
- Eimear Kenny
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Jun Zhu
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Sema4)
- Vahram Haroutunian
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
JJ Peters VA Medical Center)
- Pavel Katsel
(Icahn School of Medicine at Mount Sinai
JJ Peters VA Medical Center)
- Sam Gandy
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
JJ Peters VA Medical Center)
- Zhidong Tu
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Michelle E. Ehrlich
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Bin Zhang
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Stephen R. Salton
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Eric E. Schadt
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Sema4)
Abstract
Though discovered over 100 years ago, the molecular foundation of sporadic Alzheimer’s disease (AD) remains elusive. To better characterize the complex nature of AD, we constructed multiscale causal networks on a large human AD multi-omics dataset, integrating clinical features of AD, DNA variation, and gene- and protein-expression. These probabilistic causal models enabled detection, prioritization and replication of high-confidence master regulators of AD-associated networks, including the top predicted regulator, VGF. Overexpression of neuropeptide precursor VGF in 5xFAD mice partially rescued beta-amyloid-mediated memory impairment and neuropathology. Molecular validation of network predictions downstream of VGF was also achieved in this AD model, with significant enrichment for homologous genes identified as differentially expressed in 5xFAD brains overexpressing VGF. Our findings support a causal role for VGF in protecting against AD pathogenesis and progression.
Suggested Citation
Noam D. Beckmann & Wei-Jye Lin & Minghui Wang & Ariella T. Cohain & Alexander W. Charney & Pei Wang & Weiping Ma & Ying-Chih Wang & Cheng Jiang & Mickael Audrain & Phillip H. Comella & Amanda K. Fakir, 2020.
"Multiscale causal networks identify VGF as a key regulator of Alzheimer’s disease,"
Nature Communications, Nature, vol. 11(1), pages 1-19, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17405-z
DOI: 10.1038/s41467-020-17405-z
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Mike Thompson & Mary Grace Gordon & Andrew Lu & Anchit Tandon & Eran Halperin & Alexander Gusev & Chun Jimmie Ye & Brunilda Balliu & Noah Zaitlen, 2022.
"Multi-context genetic modeling of transcriptional regulation resolves novel disease loci,"
Nature Communications, Nature, vol. 13(1), pages 1-15, December.
- Ryan G. Lim & Osama Al-Dalahmah & Jie Wu & Maxwell P. Gold & Jack C. Reidling & Guomei Tang & Miriam Adam & David K. Dansu & Hye-Jin Park & Patrizia Casaccia & Ricardo Miramontes & Andrea M. Reyes-Ort, 2022.
"Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation,"
Nature Communications, Nature, vol. 13(1), pages 1-23, December.
- Szi Kay Leung & Rosemary A. Bamford & Aaron R. Jeffries & Isabel Castanho & Barry Chioza & Christine S. Flaxman & Karen Moore & Emma L. Dempster & Joshua Harvey & Jonathan T. Brown & Zeshan Ahmed & Pa, 2024.
"Long-read transcript sequencing identifies differential isoform expression in the entorhinal cortex in a transgenic model of tau pathology,"
Nature Communications, Nature, vol. 15(1), pages 1-19, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-17405-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.